Seeking Alpha

Kevin Porter

Kevin Porter
Send Message
View as an RSS Feed
View Kevin Porter's Comments BY TICKER:
Latest  |  Highest rated
  • EnteroMedics May Enter The Obesity Space - What Does It Mean? [View article]
    you are the only pumper here reporting COMPLETELY FALSE info

    food intake is reduced because you feel full not because you have to eat certain things and avoid a lot of other things, completely different situation

    end of discussion.
    Dec 19, 2014. 08:25 AM | Likes Like |Link to Comment
  • EnteroMedics May Enter The Obesity Space - What Does It Mean? [View article]
    99% of the 20 Million people eligible for bariatric surgery don't like or accept the risks or don't like or accept the complete and drastic diet change they need to take for the rest of their life

    VBLOC is the only softer surgery solution and no drastic diet change is needed

    not only it's realistic it will capture 5% of the bariatric numbers (5% of 220k = 11k) but it will very likely also capture a good part of the 99% who don't accept the bariatric risks (X% of 20 Million)

    Even just 1% of that is 200k extra procedures
    0.1% is 20k extra procedures

    The potential is huge

    and this is just the US, then add Europe and Australia, and possibly Mexico Japan and China are next
    Dec 18, 2014. 06:09 PM | Likes Like |Link to Comment
  • EnteroMedics May Enter The Obesity Space - What Does It Mean? [View article]
    NVRO going even more, almost 1B cap now

    ETRM is really a steal at this price !
    Dec 5, 2014. 02:55 PM | 1 Like Like |Link to Comment
  • Nevro Corporation Standing Tall, Heading Into Quiet Period Expiration [View article]
    NVRO going even more, almost 1B cap now

    ETRM is really a steal at this price
    Dec 5, 2014. 02:55 PM | Likes Like |Link to Comment
  • Nevro - I Remain Cautious After A Successful Debut For This Pain Relief Company [View article]
    NVRO going even more, almost 1B cap now !

    ETRM is really a steal at this price
    Dec 5, 2014. 02:55 PM | Likes Like |Link to Comment
  • Nevro - I Remain Cautious After A Successful Debut For This Pain Relief Company [View article]
    NVRO trading at a 'rich' 850M cap

    its medical device uses neuromodulation just like ETRM's VBLOC and it's approved in Europe and Australia while waiting FDA approval just like ETRM's VBLOC

    ETRM is an easy long, way undervalued.
    Dec 4, 2014. 02:26 PM | Likes Like |Link to Comment
  • Nevro Corporation Standing Tall, Heading Into Quiet Period Expiration [View article]
    NVRO trading at a 'rich' 850M cap

    its medical device uses neuromodulation just like ETRM's VBLOC and it's approved in Europe and Australia while waiting FDA approval just like ETRM's VBLOC

    ETRM is an easy long, way undervalued
    Dec 4, 2014. 02:25 PM | Likes Like |Link to Comment
  • EnteroMedics May Enter The Obesity Space - What Does It Mean? [View article]
    Look at NVRO, it's trading at 850M cap

    its medical device uses neuromodulation just like ETRM's VBLOC and it's approved in Europe and Australia while waiting FDA approval just like ETRM's VBLOC
    Dec 4, 2014. 02:24 PM | 1 Like Like |Link to Comment
  • Arena Pharmaceutical's Belviq Requires Patience And Understanding [View article]
    There are tons of pill makers (FDA approved and OTC) which are not much effective and have really a lot of sides, especially the ones with higher efficacy, and then you have 220k/year barbaric bariatric surgeries which are very effective but are a nightmare too. People don't want their GI tracts rerouted, their stomachs cut up, their intestines involved.... They don't want the nasty sides and the risks. They don't want to go on special diets and if they eat the wrong thing they get dumping syndrome or throw up.

    There's nothing in the middle but ETRM, it will capture 100% of the middle market.
    It's pretty effective 10% TBL and very safe.
    It is reversible, it does not change eating habits.
    It's the smart way to go, by far the best benefits vs risks choice.

    ETRM currently trades at less than 100M market cap which is ridiculously low compared to ARNA OREX and VVUS.

    MDT paid about $350 millions (260+royalties) for Transneuronix 10 years ago for its device that didn't even work and failed miserably its trial. Results were so bad that they didn't even ask for FDA approval.

    Now you have:
    * Much much better efficacy and safety
    * FDA approval (if it's approved and the buyout comes out after the approval)
    * 10 years of inflation
    * Obesity rate much higher than 10 years ago
    * Worldwide rights (I don't know if Transneuronix had ww rights too)

    So what do the 350 millions become ? I think 500 at the very least, probably more ($6 a share or more)

    btw If you want to follow my picks I post all my trades in realtime through my Instablogs.

    ETRM is an easy long
    Nov 29, 2014. 11:48 AM | 1 Like Like |Link to Comment
  • YTD 2014 Picks Recap [View instapost]
    Pretty good news for ETRM

    Nov. 25 implementation date for Japan’s new Pharmaceutical and Medical Device Law (PMDL)

    The PMDL creates a framework for regulation of medical devices and diagnostics that takes into account their unique characteristics and will help improve patient access to safe and effective medical innovations in Japan – the world’s second largest market for medical technology products.

    More here
    http://bit.ly/1vlYyZo
    Nov 26, 2014. 02:18 PM | Likes Like |Link to Comment
  • EnteroMedics May Enter The Obesity Space - What Does It Mean? [View article]
    Pretty good news for ETRM

    Nov. 25 implementation date for Japan’s new Pharmaceutical and Medical Device Law (PMDL)

    The PMDL creates a framework for regulation of medical devices and diagnostics that takes into account their unique characteristics and will help improve patient access to safe and effective medical innovations in Japan – the world’s second largest market for medical technology products.

    More here:
    http://bit.ly/1vlYyZo
    Nov 26, 2014. 02:17 PM | 3 Likes Like |Link to Comment
  • EnteroMedics May Enter The Obesity Space - What Does It Mean? [View article]
    ETRM Key Info on Conf Call Today @ Canaccord

    http://bit.ly/1r251mX

    -"We are literally waiting for FDA Approval any day now." (1:30)

    FDA Dialogue Has Specific Requests from it: (3:45 min mark-FDA Feedback)

    *Company has been in continued active dialogue with the FDA. The FDA has asked the company 3 specific questions regarding their PMA.

    (6:30 FDA Dialogue Questions)

    #1) With Approval what would a post-approval registry look like.

    #2) What would the ETRM labeling look like & how should it be worded.

    #3) What Instructions for use of the Maestro should look like.

    -Believe they have closed on all of the items the FDA has asked for and waiting for review to complete.
    -Just hired a Chief Commercial Officer.
    -Company already has CAT 3 codes. Will apply for CAT 1 code on approval.
    -Where will provider place the MAESTRO in the treatment paradigm
    -Looking for partners for distribution outside the U.S. & for exploring indications
    Nov 20, 2014. 06:52 PM | 3 Likes Like |Link to Comment
  • EnteroMedics May Enter The Obesity Space - What Does It Mean? [View article]
    20 November 2014, Obesity 'costing same as smoking'

    The worldwide cost of obesity is about the same as smoking or armed conflict and greater than both alcoholism and climate change, research has suggested.

    The McKinsey Global Institute said it cost £1.3tn, or 2.8% of annual economic activity - it cost the UK £47bn.

    Some 2.1bn people - about 30% of the world's population - were overweight or obese, the researchers added.

    They said measures that relied less on individual responsibility should be used to tackle the problem.

    The report said there was a "steep economic toll", and the proportion could rise to almost half of the world's population by 2030.

    The financial costs of obesity are growing - for health care and more widely in the economy. By causing illness, obesity results in working days and output lost.

    The researchers argued that a range of ambitious policies needed to be considered and a systemic rather than piecemeal response was essential.

    More Here: http://bbc.in/1r19RRs
    Nov 20, 2014. 12:59 PM | 3 Likes Like |Link to Comment
  • EnteroMedics May Enter The Obesity Space - What Does It Mean? [View article]
    dax, it's any day
    Nov 19, 2014. 09:54 AM | 1 Like Like |Link to Comment
  • EnteroMedics May Enter The Obesity Space - What Does It Mean? [View article]
    @ tgallo

    20k procedures a year is actually a very big number -> 150M revenues -> 1.5B valuation -> 20$ a share

    To simplify

    20k procedures a year -> 20$ a share
    10k procedures a year -> 10$ a share
    5k procedures a year -> 5$ a share

    Clearly the potential is huge since it's trading in the low $1s
    Nov 19, 2014. 07:15 AM | 1 Like Like |Link to Comment
COMMENTS STATS
1,792 Comments
3,408 Likes